BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33968780)

  • 1. KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma.
    Li Z; Yu B; Qi F; Li F
    Front Oncol; 2021; 11():670218. PubMed ID: 33968780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of KIF20A as a prognostic factor and therapeutic target for lung adenocarcinoma using integrated bioinformatics analysis.
    Sun D; Zhang H; Zhang C; Wang L
    Front Bioeng Biotechnol; 2022; 10():993820. PubMed ID: 36619388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
    Chen J; Zhou R
    PeerJ; 2021; 9():e10628. PubMed ID: 33520448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
    Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH
    PeerJ; 2020; 8():e9530. PubMed ID: 32775050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HELLS Knockdown Inhibits the Malignant Progression of Lung Adenocarcinoma Via Blocking Akt/CREB Pathway by Downregulating KIF11.
    Yang G; Fu J; Wang J; Ding M
    Mol Biotechnol; 2024 Mar; ():. PubMed ID: 38478260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma
    Li Z; Fei H; Lei S; Hao F; Yang L; Li W; Zhang L; Fei R
    PeerJ; 2021; 9():e12624. PubMed ID: 35036134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR2 and PTPRC are regulators of tumor microenvironment and potential prognostic biomarkers of lung adenocarcinoma.
    Wei J; Fang D; Zhou W
    Ann Transl Med; 2021 Sep; 9(18):1419. PubMed ID: 34733971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.
    Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K
    J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
    Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
    Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
    Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying M1-like macrophage related genes for prognosis prediction in lung adenocarcinoma based on a gene co-expression network.
    Wang Z; Yan S; Yang Y; Luo X; Wang X; Tang K; Zhao J; He Y; Bian L
    Heliyon; 2023 Jan; 9(1):e12798. PubMed ID: 36711278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Genomic Instability of m
    Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906
    [No Abstract]   [Full Text] [Related]  

  • 18. NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma.
    Zhao C; Liu J; Zhou H; Qian X; Sun H; Chen X; Zheng M; Bian T; Liu L; Liu Y; Zhang J
    Cancer Cell Int; 2021 Apr; 21(1):228. PubMed ID: 33879165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside.
    Wang X; Xiao Z; Gong J; Liu Z; Zhang M; Zhang Z
    Transl Lung Cancer Res; 2021 Jan; 10(1):167-182. PubMed ID: 33569302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining.
    Bi KW; Wei XG; Qin XX; Li B
    Front Oncol; 2020; 10():424. PubMed ID: 32351880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.